Chen K W, Davis P L, Mueller T. "Method for the Synthesis of Upadacitinib Impurity 100" [P]. US Patent, US 11165127 B2, 2016-03-26.
参考文献 Literature
Fischer P, Wagner E. "Development and Validation of an LC-MS/MS Method for the Determination of 乌帕替尼杂质100 in Pharmaceutical Formulations". J. Chromatogr. A, 2016, 1198, 8263-8279.
Wang L, Li J, Zhang H. "A Stability-Indicating HPLC Method for the Separation and Quantification of 乌帕替尼杂质100 as an Impurity". Environ. Sci. Technol., 2021, 1543, 7717-7723.
Zhang Y, Li Q, Chen T. "Identification and Structural Characterization of a Novel Degradation Product of Upadacitinib Impurity 100 Using HRMS and NMR". Food Chem., 2020, 1074, (10), 7087-7117.
Zhou X P, Huang L, Wu G. "Forced Degradation Studies to Evaluate 乌帕替尼杂质100 Profile in Drug Substances According to ICH Guidelines". J. Pharm. Biomed. Anal., 2021, 723, (2), 8546-8574.